Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
7 pending office actions • 5 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
University of Ottawa is managing 7 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 7 distinct examiners. The portfolio involves 5 distinct art units.
HOEKSTRA, JEFFREY GERBEN is the busiest examiner for the company, currently overseeing 1 pending action. With 7 pending office actions and 7 distinct examiners, every pending case is being reviewed by a different individual. This distribution across 5 distinct art units indicates a diverse set of examiner perspectives within the Biotechnology & Pharmaceuticals field.
The involvement of 7 distinct examiners for 7 pending office actions means that the university's prosecution is highly decentralized. Practitioners must adapt to different examiner styles while navigating the technical requirements of 5 distinct art units. The 1 action per examiner ensures that no single individual controls the pending portfolio.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (29%) |
| §103 only | 1 (14%) |
| §112 only | 1 (14%) |
| Double-patenting + other | 1 (14%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOEKSTRA, JEFFREY GERBEN | 1 | 56.5% | +39.1% |
| GOUGH, TIFFANY MAUREEN | 1 | 31.6% | +46.8% |
| ARIANI, KADE | 1 | 74.9% | +32.4% |
| NATARAJAN, MEERA | 1 | 62.5% | +18.0% |
| DONOHUE, SEAN R | 1 | 41.4% | +21.0% |
| KERR, ELIZABETH M | 1 | 64.7% | +27.7% |
| HOERNER, PAUL ELLSWORTH | 1 | 50.0% | +62.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18343960 | METHODS AND COMPOUNDS FOR DETECTION AND BINDING OF ALDEHYDES | DONOHUE, SEAN R | 15d |
| 17899230 | FAST REPLICATION OF LASER MACHINED MICRON/SUB-MICRON SCALE PATTERNS ONTO SOFT-METAL SUBSTRATES VIA EMBOSSING | KERR, ELIZABETH M | 41d |
| 19058822 | SYSTEMS AND METHODS FOR EVALUATING GAIT | HOEKSTRA, JEFFREY GERBEN | — |
| 18816776 | LIGILACTOBACILLUS PROBIOTICS, LIGILACTOBACILLUS EXTRACELLULAR VESICLES AND METHODS OF USING SAME | ARIANI, KADE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17774875 | BIOMATERIALS FOR BONE TISSUE ENGINEERING | HOERNER, PAUL ELLSWORTH | 72d overdue |
| 18343960 | METHODS AND COMPOUNDS FOR DETECTION AND BINDING OF ALDEHYDES | DONOHUE, SEAN R | 15d |
| 17899230 | FAST REPLICATION OF LASER MACHINED MICRON/SUB-MICRON SCALE PATTERNS ONTO SOFT-METAL SUBSTRATES VIA EMBOSSING | KERR, ELIZABETH M | 41d |
| 19058822 | SYSTEMS AND METHODS FOR EVALUATING GAIT | HOEKSTRA, JEFFREY GERBEN | — |
| 18978215 | PROBIOTIC COMPOSITIONS AND METHODS | GOUGH, TIFFANY MAUREEN | — |
| 18816776 | LIGILACTOBACILLUS PROBIOTICS, LIGILACTOBACILLUS EXTRACELLULAR VESICLES AND METHODS OF USING SAME | ARIANI, KADE | — |
| 18699059 | ANTI-CD3 MONOCLONAL ANTIBODIES AND THERAPEUTIC CONSTRUCTS | NATARAJAN, MEERA | — |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| 1651 | 1 |
| 1618 | 1 |
| 3761 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19058822 | SYSTEMS AND METHODS FOR EVALUATING GAIT | HOEKSTRA, JEFFREY GERBEN | 3791 | §101§102§112 | Non-Final OA | — | Pending | Feb 20, 2025 |
| 18978215 | PROBIOTIC COMPOSITIONS AND METHODS | GOUGH, TIFFANY MAUREEN | 1651 | §102DP | Non-Final OA | — | Pending | Dec 12, 2024 |
| 18816776 | LIGILACTOBACILLUS PROBIOTICS, LIGILACTOBACILLUS EXTRACELLULAR VESICLES AND METHODS OF USING SAME | ARIANI, KADE | — | §101§102§103§112 | Non-Final OA | — | Pending | Aug 27, 2024 |
| 18699059 | ANTI-CD3 MONOCLONAL ANTIBODIES AND THERAPEUTIC CONSTRUCTS | NATARAJAN, MEERA | — | §112 | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18343960 | METHODS AND COMPOUNDS FOR DETECTION AND BINDING OF ALDEHYDES | DONOHUE, SEAN R | 1618 | §102§103§112 | Final Rejection | 15d | Pending | Jun 29, 2023 |
| 17899230 | FAST REPLICATION OF LASER MACHINED MICRON/SUB-MICRON SCALE PATTERNS ONTO SOFT-METAL SUBSTRATES VIA EMBOSSING | KERR, ELIZABETH M | 3761 | §103§112 | Final Rejection | 41d | Pending | Aug 30, 2022 |
| 17774875 | BIOMATERIALS FOR BONE TISSUE ENGINEERING | HOERNER, PAUL ELLSWORTH | 1611 | §103 | Non-Final OA | 72d overdue | Pending | May 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial